title: The NR3C1 Glucocorticoid Receptor Gene Polymorphisms May Modulate the TGF-beta mRNA Expression in Asthma Patients.
abstract: Glucocorticosteroids (GCs) are basic drugs in therapy of a number of diseases, including chronic diseases of the respiratory system. They are the most important anti-inflammatory drugs in the treatment of asthma. GCs after binding to the glucocorticoid receptor (GR) form the complex (transcription factor), which acts on promoter and regulatory parts of genes enhancing the expression of anti-inflammatory proteins and decreasing the proinflammatory protein synthesis, including numerous cytokines mediating inflammation in the course of asthma. Non-sensitivity or resistance to GCs favours an increase in the TGF-β expression. This cytokine plays a central role in asthma inducing fibroblast differentiation and extracellular matrix synthesis. TGF-β isoforms, 1, 2 and 3, are located on chromosome 19q13, 1q41 and 14q24, respectively. GCs reduce TGF-β 1 and TGF-β 2 production and significantly decrease the expression of upregulated TGF-β 1 and TGF-β 2 mRNA induced by exogenous TGF-β. In asthma, TGF-β may play a role in the development of the peribronchiolar and subepithelial fibrosis, which contributes to a significant clinical exacerbation of asthma. Therefore, it is possible that NR3C1 glucocorticoid receptor gene polymorphisms could exert varied effects on the TGF-β mRNA expression and fibrotic process in lungs of asthmatic patients. The aim of the study was to evaluate the impact of polymorphic forms (Tth111I, BclI, ER22/23EK, N363S) of the NR3C1 gene on the level of the TGF-β 1 mRNA expression. A total of 173 patients with asthma and 163 healthy volunteers participated in the study. Genotyping of Tth111I, BclI, ER22/23EK, and N363S polymorphisms of the NR3C1 gene was performed by using PCR-HRM and PCR-RFLP techniques. TGF-β mRNA was assessed by real time RT-PCR. Tth111I SNP significantly (p = 0.0115) correlated with the TGF-β 1 mRNA expression level. The significance of AA and GG genotypes of Tth111I SNP in increasing and decreasing the level of the TGF-β 1 mRNA expression was demonstrated. Both BclI SNP and ER22/23EK SNP did not affect the expression level of the cytokine analysed. The N363S SNP AA genotype of NR3C1 gene statistically significantly influenced the increase in the level of the TGF-β 1 mRNA expression. Thus, SNPs of NR3C1 gene play an important regulatory function in the bronchi of patients suffering from asthma. In the case of the occurrence of Tth111I and N363S polymorphic forms of the gene studied, a reduced ability of GCs to inhibit the TGF-β 1 expression can be observed.
authors: Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, 22 Kopcinskiego Str, 90-153, Lodz, Poland, michalmp@poczta.onet.pl.
authors: Michał
authors: M
authors: Panek
authors: Tadeusz
authors: T
authors: Pietras
authors: Artur
authors: A
authors: Fabijan
authors: Jan
authors: J
authors: Zioło
authors: Łukasz
authors: Ł
authors: Wieteska
authors: Beata
authors: B
authors: Małachowska
authors: Wojciech
authors: W
authors: Fendler
authors: Janusz
authors: J
authors: Szemraj
authors: Piotr
authors: P
authors: Kuna
mesh_terms: D000328:Adult; D000368:Aged; D001249:Asthma / Q000235:genetics* / Q000378:metabolism*; D001980:Bronchi / Q000378:metabolism; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D012333:RNA, Messenger / Q000096:biosynthesis*; D011965:Receptors, Glucocorticoid / Q000235:genetics*; D053773:Transforming Growth Factor beta1 / Q000096:biosynthesis*
chemical_list: C497713:NR3C1 protein, human; D012333:RNA, Messenger; D011965:Receptors, Glucocorticoid; D053773:Transforming Growth Factor beta1
references: Nature. 1991 Aug 8;352(6335):497-505
references: 1865905
references: J Biol Chem. 2004 Jan 9;279(2):1359-67
references: 14576166
references: Int J Biochem Mol Biol. 2013 Mar 31;4(1):67-74
references: 23638322
references: Obesity (Silver Spring). 2006 May;14(5):759-64
references: 16855182
references: Eur Respir J. 2008 Jan;31(1):143-78
references: 18166595
references: Recent Prog Horm Res. 2004;59:333-57
references: 14749509
references: J Clin Endocrinol Metab. 1993 Mar;76(3):683-9
references: 8445027
references: Am J Med Genet. 2000 Jun 12;96(3):412-7
references: 10898924
references: Exp Ther Med. 2013 Feb;5(2):572-580
references: 23407653
references: Nucleic Acids Res. 1991 Apr 25;19(8):1960
references: 1674374
references: World J Gastroenterol. 2011 Mar 7;17(9):1095-108
references: 21448414
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: J Immunol. 2005 May 1;174(9):5774-80
references: 15843580
references: J Allergy Clin Immunol. 2004 Jan;113(1):59-65
references: 14713908
references: J Allergy Clin Immunol. 2007 Jun;119(6):1337-48
references: 17416409
references: J Clin Endocrinol Metab. 2006 Jul;91(7):2800-3
references: 16684836
references: Respir Res. 2013 Nov 01;14:118
references: 24283210
references: Metabolism. 2000 Sep;49(9):1197-9
references: 11016903
references: Br Med J (Clin Res Ed). 1981 May 2;282(6274):1419-22
references: 6784848
references: Endocr Relat Cancer. 2006 Jun;13(2):379-400
references: 16728569
references: Anal Biochem. 1999 May 15;270(1):41-9
references: 10328763
references: Mol Vis. 2007 Apr 27;13:659-66
references: 17563720
references: J Clin Endocrinol Metab. 2005 Oct;90(10):5804-10
references: 16030164
references: Nat Rev Cancer. 2006 Jul;6(7):506-20
references: 16794634
references: J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):457-67
references: 12943736
references: J Clin Endocrinol Metab. 1998 Jan;83(1):144-51
references: 9435432
references: Mol Biol Cell. 2004 Feb;15(2):420-34
references: 14595120
references: Am Rev Respir Dis. 1991 Nov;144(5):1016-25
references: 1952426
references: Clin Med Res. 2003 Jan;1(1):13-20
references: 15931280
references: Curr Allergy Asthma Rep. 2008 Apr;8(2):171-8
references: 18417060
references: Steroids. 1996 Apr;61(4):157-60
references: 8732992
references: J Biochem Mol Biol. 2002 Jan 31;35(1):47-53
references: 16248969
references: Eur Respir J. 2006 Feb;27(2):413-26
references: 16452600
references: Inflammation. 2002 Dec;26(6):279-90
references: 12546137
references: Eur Respir J. 2005 Aug;26(2):319-38
references: 16055882
references: Nephrol Dial Transplant. 2008 Jan;23(1):47-51
references: 17890752
references: J Clin Endocrinol Metab. 2004 Feb;89(2):892-7
references: 14764810
references: Eur J Pharmacol. 2006 Mar 8;533(1-3):118-32
references: 16469308
references: Mediators Inflamm. 1998;7(4):229-37
references: 9792333
references: Nat Rev Drug Discov. 2004 Oct;3(10):831-44
references: 15459674
references: J Steroid Biochem Mol Biol. 2002 Jun;81(2):103-22
references: 12137800
references: Treat Respir Med. 2005;4(6):365-79
references: 16336023
references: Biochem Soc Trans. 2006 Jun;34(Pt 3):458-60
references: 16709187
references: Mol Biol Rep. 2012 Apr;39(4):4749-57
references: 22015776
references: Eur J Pharmacol. 2008 Apr 7;583(2-3):303-11
references: 18321483
references: J Allergy Clin Immunol. 2003 Jan;111(1):3-22; quiz 23
references: 12532089
references: Mol Endocrinol. 1997 Jul;11(8):1156-64
references: 9212062
references: J Clin Endocrinol Metab. 2004 Aug;89(8):4004-9
references: 15292341
references: Mol Biol Rep. 2011 Aug;38(6):3953-8
references: 21113676
references: J Microbiol Immunol Infect. 2004 Jun;37(3):145-52
references: 15221033
references: Recent Prog Horm Res. 1985;41:199-247
references: 2996089
references: Int J Mol Med. 2012 Jul;30(1):142-50
references: 22469783
references: Anal Biochem. 1987 Apr;162(1):156-9
references: 2440339
references: J Allergy Clin Immunol. 2006 Mar;117(3):522-43
references: 16522450
references: Steroids. 2010 Jan;75(1):1-12
references: 19818358
references: Hum Mutat. 2003 Jun;21(6):557-68
references: 12754700
references: Postepy Hig Med Dosw (Online). 2008 Dec 12;62:688-93
references: 19188884
references: Med Sci Monit. 2010 Oct;16(10):CR475-9
references: 20885351